Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.

Animals CD4-Positive T-Lymphocytes / drug effects Cell Proliferation / drug effects Cytokines / biosynthesis Disease Models, Animal Host-Pathogen Interactions / immunology Human T-lymphotropic virus 1 / drug effects Humans Immunity, Cellular / drug effects Immunologic Factors / therapeutic use Leukemia-Lymphoma, Adult T-Cell / drug therapy Lymphocyte Activation / drug effects Neurons / drug effects Neuroprotective Agents / therapeutic use Paraparesis, Tropical Spastic / drug therapy Spinal Cord / drug effects T-Lymphocytes, Cytotoxic / drug effects Urinary Incontinence / drug therapy
HAM/TSP HTLV-1 Immunology Neurological disorders Pathogenesis

Journal

Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 03 2020
accepted: 06 07 2020
revised: 29 03 2020
pubmed: 25 7 2020
medline: 19 8 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Human T-lymphotropic virus type 1 (HTLV-1) is associated with adult T cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HAM/TSP is an inflammatory disease of the spinal cord and clinically characterized by progressive spastic paraparesis, urinary incontinence, and mild sensory disturbance. The interaction between the host immune response and HTLV-1-infected cells regulates the development of HAM/TSP. HTLV-1 preferentially infects CD4

Identifiants

DOI: 10.1007/s13365-020-00881-w PMID: 32705480 PMC: PMC7532128
pubmed: 32705480
doi: 10.1007/s13365-020-00881-w
pii: 10.1007/s13365-020-00881-w
pmc: PMC7532128
doi:

Substances chimiques

Cytokines 0
Immunologic Factors 0
Neuroprotective Agents 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

652-663

Références

J Immunol. 1998 Jul 1;161(1):482-8
pubmed: 9647259
Front Microbiol. 2018 Mar 20;9:461
pubmed: 29615995
Acta Neuropathol. 2000 Sep;100(3):245-52
pubmed: 10965793
J Neuropathol Exp Neurol. 2015 Jan;74(1):2-14
pubmed: 25470342
J Infect Dis. 2011 Feb 15;203(4):529-36
pubmed: 21208912
Retrovirology. 2018 Nov 6;15(1):72
pubmed: 30400920
Blood. 2003 Apr 15;101(8):3074-81
pubmed: 12480698
J Infect Dis. 2006 Jun 1;193(11):1557-66
pubmed: 16652285
BMC Biotechnol. 2017 Jul 10;17(1):61
pubmed: 28693542
Cancer Res. 2004 Jan 1;64(1):391-9
pubmed: 14729650
Front Microbiol. 2012 Jun 21;3:222
pubmed: 22737146
Immunity. 2016 May 17;44(5):1069-78
pubmed: 27192570
J Neurovirol. 1996 Oct;2(5):345-55
pubmed: 8912211
PLoS Pathog. 2016 Jan 06;12(1):e1005372
pubmed: 26735971
PLoS Negl Trop Dis. 2017 Jan 17;11(1):e0005285
pubmed: 28095504
PLoS Pathog. 2010 Sep 23;6(9):e1001117
pubmed: 20886101
Ann Neurol. 2001 Dec;50(6):807-12
pubmed: 11761481
J Gen Virol. 2005 May;86(Pt 5):1515-1523
pubmed: 15831965
Oncol Res. 2013;20(9):403-10
pubmed: 23924924
Lancet. 1986 May 3;1(8488):1031-2
pubmed: 2871307
PLoS Pathog. 2011 Feb 10;7(2):e1001274
pubmed: 21347344
J Gen Virol. 2009 Aug;90(Pt 8):1806-1811
pubmed: 19423550
J Immunol. 1998 Dec 15;161(12):6674-80
pubmed: 9862696
Blood. 2008 Nov 1;112(9):3788-97
pubmed: 18689544
Blood. 2011 May 5;117(18):4855-9
pubmed: 21398577
ILAR J. 2016;57(1):3-11
pubmed: 27034390
Blood. 2012 Oct 25;120(17):3488-90
pubmed: 22955925
Virology (Auckl). 2013 Nov 18;4:49-59
pubmed: 25512694
Neuropathology. 2000 Sep;20 Suppl:S65-8
pubmed: 11037191
Hum Immunol. 2011 Nov;72(11):1001-6
pubmed: 21851845
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Annu Rev Immunol. 2018 Apr 26;36:43-71
pubmed: 29144838
Blood. 2018 Jan 11;131(2):215-225
pubmed: 29084771
Front Microbiol. 2019 Apr 26;10:819
pubmed: 31080441
PLoS One. 2014 Mar 31;9(3):e93374
pubmed: 24686382
J Neuroimmunol. 2017 Mar 15;304:51-55
pubmed: 27542993
Sci Rep. 2019 Jan 23;9(1):344
pubmed: 30674904
Viruses. 2011 Jun;3(6):794-810
pubmed: 21994754
PLoS One. 2009 Aug 05;4(8):e6517
pubmed: 19654865
Blood. 1977 Sep;50(3):481-92
pubmed: 301762
Ann Neurol. 1996 Jul;40(1):84-90
pubmed: 8687197
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7568-73
pubmed: 9636190
J Virol. 1995 Sep;69(9):5925-7
pubmed: 7637041
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3054-9
pubmed: 26929370
Eur J Haematol. 2017 Dec;99(6):495-504
pubmed: 28833639
J Virol. 2001 Jan;75(2):1065-71
pubmed: 11134322
Lancet. 1985 Aug 24;2(8452):407-10
pubmed: 2863442
Immunity. 2016 May 17;44(5):1052-68
pubmed: 27192569
Acta Neuropathol. 1999 Feb;97(2):107-12
pubmed: 9928820
Blood. 2011 Aug 18;118(7):1865-76
pubmed: 21705495
Leukemia. 2009 Feb;23(2):375-82
pubmed: 18830259
Neurology. 1996 Apr;46(4):1016-21
pubmed: 8780082
Orphanet J Rare Dis. 2016 May 25;11(1):69
pubmed: 27225443
PLoS One. 2014 May 06;9(5):e86144
pubmed: 24802839
Wellcome Open Res. 2017 Sep 22;2:87
pubmed: 29062917
Adv Cancer Res. 2011;111:163-82
pubmed: 21704832
J Exp Med. 1992 Oct 1;176(4):981-9
pubmed: 1402668
Med J Aust. 2016 Oct 3;205(7):305-9
pubmed: 27681971
N Engl J Med. 2018 Feb 8;378(6):529-538
pubmed: 29414279
J Clin Invest. 2014 Aug;124(8):3431-42
pubmed: 24960164
Eur J Immunol. 2009 Jul;39(7):1700-12
pubmed: 19582737
Clin Transl Med. 2018 Aug 27;7(1):24
pubmed: 30146667
Antimicrob Agents Chemother. 2011 May;55(5):2011-7
pubmed: 21343468
J Neurovirol. 2016 Aug;22(4):416-30
pubmed: 26635027
Oncogene. 2011 Mar 24;30(12):1379-89
pubmed: 21119600
J Virol. 2002 Dec;76(24):12813-22
pubmed: 12438606
J Neurovirol. 2007 Aug;13(4):364-72
pubmed: 17849320
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1269-E1278
pubmed: 29358408
J Immunol. 1999 Oct 1;163(7):4064-72
pubmed: 10491011
Front Microbiol. 2016 Oct 28;7:1674
pubmed: 27840624
PLoS Pathog. 2017 Nov 29;13(11):e1006722
pubmed: 29186194
J Immunol. 2008 Jan 15;180(2):931-9
pubmed: 18178833
Rev Neurol (Paris). 2012 Mar;168(3):257-69
pubmed: 22405461
Blood. 2000 Feb 15;95(4):1386-92
pubmed: 10666215
Front Microbiol. 2017 Dec 21;8:2563
pubmed: 29312243
J Neuropathol Exp Neurol. 1993 Jul;52(4):424-30
pubmed: 8355031
Retrovirology. 2013 Feb 13;10:19
pubmed: 23405908
N Engl J Med. 2018 Aug 16;379(7):695
pubmed: 30124278
PLoS Pathog. 2014 Apr 03;10(4):e1004040
pubmed: 24699669
Blood. 2002 Jan 1;99(1):88-94
pubmed: 11756157
J Virol. 2001 Oct;75(20):9836-43
pubmed: 11559817
Oncogene. 2016 Aug 25;35(34):4509-17
pubmed: 26804169
NPJ Genom Med. 2019 May 6;4:10
pubmed: 31069115
J Neuropathol Exp Neurol. 1994 Nov;53(6):617-24
pubmed: 7964902
PLoS Pathog. 2013 Sep;9(9):e1003630
pubmed: 24068936
Oncogene. 2005 Sep 5;24(39):6005-15
pubmed: 16155607
Viruses. 2011 May;3(5):469-83
pubmed: 21994743
Retrovirology. 2006 Sep 19;3:63
pubmed: 16984654
Retrovirology. 2017 Apr 19;14(1):26
pubmed: 28420387
Cancer Res. 2016 Sep 1;76(17):5068-79
pubmed: 27402079
J Neurol Sci. 1990 Apr;96(1):103-23
pubmed: 2351985
PLoS Pathog. 2009 Dec;5(12):e1000682
pubmed: 19997502
Brain. 2013 Sep;136(Pt 9):2876-87
pubmed: 23892452
Retrovirology. 2009 Feb 19;6:19
pubmed: 19228429
PLoS Pathog. 2017 Jan 3;13(1):e1006120
pubmed: 28046066
Acta Neuropathol. 1998 Oct;96(4):340-6
pubmed: 9796997
Retrovirology. 2014 Dec 14;11:116
pubmed: 25499803
J Neurol Neurosurg Psychiatry. 1993 Sep;56(9):1004-7
pubmed: 8410023
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
pubmed: 16407133
J Virol. 1991 Jul;65(7):3770-8
pubmed: 2041093
J Clin Invest. 2005 May;115(5):1361-8
pubmed: 15864353
J Exp Med. 2004 May 17;199(10):1367-77
pubmed: 15136590
Blood. 2008 Sep 15;112(6):2400-10
pubmed: 18509087
Arch Neurol. 2006 Nov;63(11):1560-6
pubmed: 17101824
J Neurovirol. 1998 Dec;4(6):586-93
pubmed: 10065900
J Neurol Sci. 2008 Jun 15;269(1-2):133-7
pubmed: 18258264
J Infect Dis. 2015 Jan 15;211(2):238-48
pubmed: 25104771
Nat Med. 2006 Apr;12(4):466-72
pubmed: 16550188
AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1711-5
pubmed: 11080815
J Neuroimmune Pharmacol. 2017 Sep;12(3):504-520
pubmed: 28374110
Front Microbiol. 2019 May 15;10:1101
pubmed: 31156605
J Clin Immunol. 2013 Oct;33(7):1223-39
pubmed: 23888327
PLoS Pathog. 2016 Nov 28;12(11):e1006030
pubmed: 27893842
Nature. 1990 Nov 15;348(6298):245-8
pubmed: 2146511
J Infect Dis. 2011 Apr 1;203(7):948-59
pubmed: 21402546
J Cell Sci. 2005 Apr 1;118(Pt 7):1355-62
pubmed: 15755797
J Infect Dis. 2000 Nov;182(5):1343-9
pubmed: 11010842
Ann Clin Transl Neurol. 2019 Aug;6(8):1383-1394
pubmed: 31402625
Jpn J Cancer Res. 1993 Aug;84(8):831-3
pubmed: 8407544

Auteurs

Satoshi Nozuma (S)

Viral Immunology Section, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Ryuji Kubota (R)

Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.

Steven Jacobson (S)

Viral Immunology Section, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. jacobsons@ninds.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD4+ › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Phénomènes biologiques › Interactions hôte-microbes › Interactions hôte-pathogène › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Virus › Virus à ARN › Retroviridae › Deltaretrovirus › Virus T-lymphotrope de type 1 des primates › Virus T-lymphotrope humain de type 1 › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité acquise › Immunité cellulaire › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Syndromes lymphoprolifératifs › Leucémie lymphoïde › Leucémie à cellules T › Leucémie-lymphome à cellules T de l'adulte › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Phénomènes du système immunitaire › Activation des lymphocytes › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Cellules › Neurones › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Neuroprotecteurs › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Maladies du système nerveux › Myélite › Paraparésie spastique tropicale › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Système nerveux › Système nerveux central › Moelle spinale › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T cytotoxiques › Human T-lymphotropic virus type 1 (HTLV-1) and...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations urologiques › Symptômes de l'appareil urinaire inférieur › Incontinence urinaire › Human T-lymphotropic virus type 1 (HTLV-1) and...